Key takeaways:
- A clinical decision tool, shared in a webinar led by GI psychologist Dr. Megan Riehl, helps providers assess patient suitability for gut-directed hypnotherapy with Nerva.
- The session covers the clinical and psychological factors that determine when gut-directed hypnotherapy is the right approach, and when other interventions may be more appropriate.
- It also explores incorporating psychological strategies into a comprehensive, multidisciplinary IBS treatment plan for more personalized patient support.
- Complete the form to watch the webinar recording, and refer patients to Nerva using the HIPAA-compliant referral form.
A new clinical decision tool – shared in a webinar led by top GI psychologist Dr. Megan Riehl – helps providers assess patient suitability for gut-directed hypnotherapy (GDH) with Nerva and optimize care pathways.
During the session, attendees gained insights into:
Evaluating patient suitability – Understanding the clinical and psychological factors that determine when Nerva and GDH is the right approach.
Identifying alternative pathways – Recognizing cases where other interventions may be more appropriate for a patient’s care.
Integrating psychological care – Incorporating psychological strategies into a comprehensive, multidisciplinary IBS treatment plan for more personalized patient support.
This webinar provided guidance on bridging the gap between traditional treatment models and a more personalized, biopsychosocial approach to IBS care.
